Carotid endarterectomy under local anaesthesia does not increase plasma homocysteine concentration

European Journal of Vascular and Endovascular Surgery

Volumn 30, Issue 6, 2005, Pages 617-620

  Assadian, Afshin ^a   Eidher, U ^a   Senekowitsch, C ^a   Assadian, O ^b   Rotter, R ^a   Hagmuller G W ^a   Hubl W ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Carotid endarterectomy; Homocysteine; Regional anaesthesia; Risk factor

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CAROTID ENDARTERECTOMY; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA, LOCAL; BIOLOGICAL MARKERS; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; TREATMENT OUTCOME;

EID: 28944446567     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.05.042     Document Type: Article

References (20)

1. J.D. Finkelstein Methionine metabolism in mammals J Nutr Biochem 1 1990 228-237
2. G. Schnyder M. Roffi Y. Flammer R. Pin O.M. Hess Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: The Swiss Heart study: A randomized controlled trial JAMA 288 2002 973-979
3. A. Becker R.M. Henry P.J. Kostense C. Jakobs T. Teerlink S. Zweegman et al. Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: Different effects in diabetic and non-diabetic individuals. The Hoorn Study Atherosclerosis 169 2003 323-330
4. E. Laxdal G.E. Eide J. Wirsching G.L. Jenssen T. Jonung G. Pedersen et al. Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery Eur J Vasc Endovasc Surg 28 2004 410-417
5. J.Y. Jeremy N. Shukla G.D. Angelini A. Day I.Y.P. Wan S.P. Talpahewa et al. Sustained increase of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting Ann Thorac Surg 74 2002 1553-1557
6. A.T. Brown H. Chen J.A. Davis I. Qureshi C.P. Cruz L.A. Poirier et al. Plasma homocysteine measurements after carotid artery manipulation and clamping in a rat CEA model J Vasc Surg 40 2004 796-802
7. J.S. Stamler A. Slivka Biological chemistry of thiols in the vasculature and in vascular related disease Nutr Rev 54 1996 1-30
8. C.B. Leerink A.D. van Ham A. Heeres P.F. Duif B.N. Bouma H.J. van Rijn Sulfhydrilcompounds influence immunorectivity, structure and functional aspects of lipoprotein(a) Thromb Res 74 1994 219-232
9. J.C. Chambers A. McGregor J. Jean-Marie O.A. Obeid J.S. Kooner Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinaemia: An effect reversible with vitamin C therapy Circulation 99 1999 1156-1169
10. M. Van den Berg G.H. Boers D.G. Franken H.J. Blom G.J. Van Kamp C. Jakobs et al. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease Eur J Clin Invest 25 1995 176-181
11. M. den Heijer T. Koster H.J. Blom G.M. Bos E. Briet P.H. Reitsma et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis N Engl J Med 334 1996 759-762
12. O.D. Ratnoff Activation of Hageman factor by L-homocystine Science 162 1968 1007-1009
13. G.M. Rodgers W.H. Kane Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator J Clin Invest 77 1986 1909-1916
14. G.M. Rodgers M.T. Conn Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells Blood 75 1990 895-901
15. S.R. Lentz J.E. Sadler Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine J Clin Invest 88 1991 1906-1914
16. R.H. Fryer B.D. Wilson D.B. Gubler L.A. Fitzgerald G.M. Rodgers Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells Arterioscler Thromb 13 1993 1327-1333
17. M. Nishinaga T. Ozawa K. Shimada Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells J Clin Invest 92 1993 1381-1386
18. J.C. Tsai M.A. Perrella M. Yoshizumi C.M. Hsieh E. Haber R. Schlegel et al. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis Proc Natl Acad Sci USA 91 1994 6369-6373
19. J.C. Tsai H. Wang M.A. Perrella M. Yoshizumi N.E. Sibinga L.C. Tan et al. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells J Clin Invest 97 1996 146-153
20. K. Rerkasem R. Bond P.M. Rothwell Local versus general anaesthesia for carotid endarterectomy Cochrane Database Syst Rev 2004 CD000126